Full-Time

Revenue Cycle Solutions Manager

Confirmed live in the last 24 hours

Natera

Natera

1,001-5,000 employees

Genetic testing and diagnostics solutions provider

Biotechnology
Healthcare

Compensation Overview

$110k - $130kAnnually

Senior, Expert

Remote in USA

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Requirements
  • Bachelor’s degree in Biology (Engineering) or equivalent. MS or PhD in Biological Sciences preferred.
  • Certifications in System administration and Systems Engineering or other certifications are a plus.
  • Minimum of 12 years of in revenue cycle, information systems, health insurance or healthcare billing Genetic testing or laboratory diagnostic experience, a plus.
  • Knowledge of configuring and setting up hardware and software.
  • Demonstrated ability to learn new systems and software applications.
Responsibilities
  • Lead and Manage RCM System Solutions related to process improvement, redesign processes.
  • Serves as a source of knowledge and performs analysis for performance improvement.
  • Lead the Collaboration and coordination with other departments impacting revenue cycle billing system solutions.
  • Help identify areas of monetary loss in the revenue cycle process.
  • Work with various teams to help keep drive them towards the goal of reducing loss in the revenue cycle process.
  • Keep track of progress made by teams in fixing areas of loss towards the goal of achieving higher revenue.
  • Ownership for tracking overall progress with status reports to leadership.
  • Tracks outcomes of billing system payment resolution, appeals, and negotiated claims.
  • Implement appropriate technology solutions to support continued improved cash collection performance.
  • Manage projects and initiatives for improved reimbursement and reporting on actual performance against these targets; continue to monitor performance for process control.
  • Meets established deadlines timely, accurately, and with a sense of urgency.
  • This role works with PHI on a regular basis both in paper and electronic form and has access to various technologies to access PHI (paper and electronic) to perform the job.
  • Employee must complete training relating to HIPAA/PHI, privacy, General Policies and Procedure Compliance training and security training as soon as possible but not later than the first 30 days of hire.
  • Must maintain a current status on Natera training requirements.
  • Performs other duties as assigned.

Natera specializes in genetic testing and diagnostics, focusing on advanced testing solutions for various medical needs. Their main technology is cell-free DNA (cfDNA) testing, which analyzes small DNA fragments in the blood to detect molecular residual disease (MRD) in cancer patients, aiding in treatment decisions. They also offer the Signatera test, a custom ctDNA test for cancer patients, accessible through their GI Expanded Access Program. In addition to oncology, Natera provides testing for organ health in transplant patients and offers a range of women's health tests, including the Panorama NIPT for prenatal screening. Natera's services are provided to healthcare providers, hospitals, and directly to patients, generating revenue through testing kits and services, often reimbursed by insurance. Their goal is to enhance patient care through precise genetic insights and support.

Company Stage

IPO

Total Funding

$149.9M

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

9%

1 year growth

25%

2 year growth

66%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased adoption of liquid biopsy techniques boosts demand for Natera's cfDNA tests.
  • AI integration enhances accuracy and speed of Natera's cfDNA analysis.
  • Growing personalized medicine trend aligns with Natera's customized genetic tests.

What critics are saying

  • Hindenburg report accuses Natera of deceptive sales practices, risking legal challenges.
  • New Prospera Heart features may face slow adoption by healthcare providers.
  • Fetal RhD NIPT demand may drop post-RhIg shortage, affecting future sales.

What makes Natera unique

  • Natera's Signatera test offers personalized ctDNA analysis for cancer patients.
  • Prospera Heart test uses unique Donor Quantity Score for transplant rejection detection.
  • Panorama NIPT test is a leader in non-invasive prenatal testing with 2 million tests.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks